PHARMACOKINETICS OF CHLORMETHIAZOLE IN HUMANS

被引：50

作者：

MOORE, RG

TRIGGS, EJ

SHANKS, CA

THOMAS, J

机构：

[1] ROY PRINCE ALFRED HOSP,SYDNEY,AUSTRALIA

[2] UNIV SYDNEY,DEPT PHARM,SYDNEY 2006,NEW S WALES,AUSTRALIA

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1975年 / 8卷 / 05期

关键词：

D O I：

10.1007/BF00562662

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：353 / 357

页数：5

共 13 条

[1]

BERMAN M, 1968, USERS MANUAL SAAM

[2]

DIEM K, 1971, SCI TABLES, P555

[3]

FISCHLER M, 1973, ACTA PHARM SUEC, V10, P483

[4]

FRISCH EP, 1966, ACTA PSYCHIAT SCAND, VS 42, P35

[5] INFLUENCE OF FIRST-PASS EFFECT ON AVAILABILITY OF DRUGS ON ORAL ADMINISTRATION [J].

GIBALDI, M ;

BOYES, RN ;

FELDMAN, S .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1971, 60 (09) :1338-&

[6]

GOLDSTEIN A, 1969, PRINCIPLES DRUG ACTI, P194

[7] METABOLISM OF CHLORMETHIAZOL IN RAT [J].

HERBERTZ, G ;

REINAUER, H .

NAUNYN-SCHMIEDEBERGS ARCHIV FUR PHARMAKOLOGIE, 1971, 270 (02) :192-&

[8] PREDICTION OF SYSTEMIC AVAILABILITY FROM PLASMA-LEVEL DATA AFTER ORAL DRUG ADMINISTRATION [J].

PERRIER, D ;

GIBALDI, M ;

BOYES, RN .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1973, 25 (03) :256-257

[9] INFLUENCE OF FIRST-PASS EFFECT ON SYSTEMIC AVAILABILITY OF PROPOXYPHENE [J].

PERRIER, D ;

GIBALDI, M .

JOURNAL OF CLINICAL PHARMACOLOGY AND NEW DRUGS, 1972, 12 (11-1) :449-&

[10]

PORTMAN GA, 1970, PHARMACOKINETICS CUR, P6

← 1 2 →